{"disease":{"id":"crimean-congo-hemorrhagic-fever","name":"crimean congo hemorrhagic fever"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06860334","title":"UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":378,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT06684431","title":"Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Karolinska Institutet","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}